Scribe Therapeutics celebrates listing day at Nasdaq MarketSite

Scribe Therapeutics is engineering purpose-built CRISPR medicines to broaden access to cardioprotective genetics for us all. Look back on $SCTX’s milestone celebration becoming #NasdaqListed and delivering a new era of scalable, transformative, and preventative genetic medicines.